F891-0213 Screening compound: 4-(1-{[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)thiophen-3-yl]sulfonyl}piperidine-4-carbonyl)morpholine

F891-0213 Screening compound: 4-(1-{[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)thiophen-3-yl]sulfonyl}piperidine-4-carbonyl)morpholine
F891-0213 Screening compound: 4-(1-{[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)thiophen-3-yl]sulfonyl}piperidine-4-carbonyl)morpholine alternative view

Chemical Structure Depiction of ChemDiv screening compound F891-0213
4-(1-{[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)thiophen-3-yl]sulfonyl}piperidine-4-carbonyl)morpholine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F891-0213

Molecular Formula

C18H24N4O5S2 (C18 H24 N4 O5 S2)

Compound Name

4-(1-{[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)thiophen-3-yl]sulfonyl}piperidine-4-carbonyl)morpholine

IUPAC name

4-(1-{[2-methyl-5-(5-methyl-124-oxadiazol-3-yl)thiophen-3-yl]sulfonyl}piperidine-4-carbonyl)morpholine

SMILES

Cc(sc(-c1noc(C)n1)c1)c1S(N(CC1)CCC1C(N1CCOCC1)=O)(=O)=O

InChI

InChI=1S/C18H24N4O5S2/c1-12-16(11-15(28-12)17-19-13(2)27-20-17)29(24,25)22-5-3-14(4-6-22)18(23)21-7-9-26-10-8-21/h11,14H,3-10H2,1-2H3

InChI Key

WACKOZXJESRJHU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27201916

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

440.54

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.633

Distribution Coefficient, logD

1.633

Water Solubility, LogSw

-2.15

Polar Surface Area

88.430

Acid Dissociation Constant (pKa)

23.63

Base Dissociation Constant (pKb)

-1.40

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

61.10

F891-0213 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

PI3K-Targeted Library (17255 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

SmartTM Library (51161 compounds)

Targeted Diversity Library (40567 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with F891-0213 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F891-0213?
Check Price and Availability of F891-0213, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F891-0213 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F891-0213
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F891-0213
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F891-0213 available by request